-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $30

Benzinga·12/17/2025 19:55:58
語音播報
Canaccord Genuity analyst William Plovanic maintains CeriBell (NASDAQ:CBLL) with a Buy and raises the price target from $29 to $30.